Harvard Bioscience
HBIO
HBIO
72 hedge funds and large institutions have $74.1M invested in Harvard Bioscience in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
Holders
72
Holding in Top 10
1
Calls
$150K
Puts
–
Top Buyers
| 1 | +$1.65M | |
| 2 | +$1.23M | |
| 3 | +$1.03M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$720K |
| 5 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
+$580K |
Top Sellers
| 1 | -$925K | |
| 2 | -$856K | |
| 3 | -$610K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$526K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$482K |